Study of various benign breast diseases

S. Selvakumaran, Mimamaychet B. Sangma


Background:Benign breast disorders can be defined as any non-malignant breast condition and encompasses a wide range of clinical and pathological disorders. BBD are very common and 1/3rd of women are suffering from this disorder in one time of their life. The aim of this study is to look at the patterns of benign breast diseases, the mode of presentation, management and to identify risk factors.

Methods: This descriptive study was done in 168 patients presented to the surgery OPD department with benign breast disorders. All the patients with breast related disease were included in this study. Both male and female patients were included in this study. Patients with obvious or biopsy proven malignant diseases were excluded in this study.

Results:The study comprised of 168 patients with BBD; the commonest being Fibroadenoma which formed 55.9% followed by fibroadenosis 20.8%. The other benign lesions observed were cystosarcoma phylloids, acute abscess, chronic abscess, tuberculous mastitis, antibioma, cysts, galactocele, gynaecomastia, traumatic fat necrosis, duct papilloma and mastalgia.

Conclusions:Benign breast disease is a neglected entity despite the fact that it constitutes the majority of breast complaints. Benign breast disease can no longer be ignored. Much more work needs to be done to collect data about the incidence and prevalence of benign breast diseases. Breast self-examination and education to the females is required for early diagnosis and prompt treatment as majority of anxiety and worry of having breast cancer can be alleviated.


Benign breast diseases, Fibroadenoma, Triple assessment

Full Text:



Rangabashyam N, Gyanprakashan D, Krishnaraj B, Manohar V, Vijayalakshmi SR, Spectrum of benign breast lesion. J Roy Coll Surgeons Edinburgh. 1983;28:369-73.

Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006;11:435-49.

Srivatsava A, Dhar A. Benign breast disease: a neglected entity. Recent Adv Surg. 2006;10:175-201.

Hughes LE, Mansel RE, Webster DJT. The approach to diagnosis and assessment of benign breast lumps benign disorders and diseases of the breast concepts and clinical management, 2nd edition. London: WB Saunders; 2005:35.

Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev. 1990;12:228-40.

Cole P, Mark Elwood J, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol. 1978;108:112-20.

Utchinson WB, Thomas DB, Hamlin WB. Risk of breast cancer in women with benign breast lesion. J Natl Cancer Inst. 1980;65:13-20.

Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement.Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053-55.

Sarnelli R, Squartini F. Fibrocystic condition and at risk lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol. 1991;18:271-9.

Bartow SA, Pathak DR, Black WC. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer. 1987;60:2751-60.

Cook MG, Rohan TE. The patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Pathol. 1985;146:1-15.

Vecchia C, Parazzini F, Franceschi S. Risk factors for benign breast disease and their relation with breast cancer risk. Pooled information from epidemiologic studies. Tumori. 1985;71:167-78.

Mansel RE. European multicentre trial of Bromocriptine in cyclic mastalgia. Lancet. 1990;335:190-92.

Khanna S, Arya NC, Khanna NN. Spectrum of benign breast disease. Indian J Surg. 1988;50:169-75.

Shukla HS, Kumar S. Benign breast disorders in nonwestern populations: Part II - Benign breast disorders in India. World J Surg. 1989;13:746-49.